COVID-19 updates - Get the latest information about Coronavirus and Iowa Heart Center

Destiny XF-73

Purpose of Study

To demonstrate the efficacy of a 0.2% XF-73 nasal gel in reducing post-operative staphylococcal infection

Trial Status

Enrolling

Eligibility Criteria

  • Between 18-75 years of age
  • confirmed nasal S. aureus carriers swab and due to undergo a surgical procedure
  • not prenant or breast feeding

Duration of Participation

Approximately 6-8 weeks

Contact Name: Ali McCombs, RN

Contact Phone: 515-235-5106

Contact Email: amccombs@iowaheart.com